Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition

Aug 1, 2013
210 Pages - Pub ID: KLI5093826
Abstract Table of Contents Search Inside Report Related Reports

Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients and at point-of-care testing by healthcare professionals.

Lateral flow (LF) devices and tests have been a popular platform for rapid immunoassays since their introduction in the mid-1980s, and since our last look at the market there has been continued interest and innovations. This report profiles over a hundred companies that currently market lateral flow tests. Many of these companies, plus more than ten additional companies, are developing innovations in lateral flow-based devices. Companies profiled in this report use lateral flow technology to develop and market a wide range of rapid tests for market segments of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.

Every critical aspect of the lateral flow test market is addressed, including the following key topics:
  • The current sales figures for LF productsand realistic projections for 2017
  • The core factors driving LF testing revenues up.
  • Breakout of LF-POC market by Self Test and Professional Breakout of LF-POC market by Key Test Segments (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other)
  • Need-to-know companies in Lateral Flow Test devices.
  • The trends to watch that could increase sales predictions.
  • Expected gains to be made by LF POC devices over lab-based immunoassays across categories.
  • Regional markets for lateral flow tests (US, Europe, Japan, ROW)
  • Companies launching innovative devices.
  • Obstacles that could trap new entrants.
Growth in lateral flow point-of-care testing is being fueled by many factors fueling growth of the point-of-care market as a whole. These include the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, cancer and other chronic conditions, and many other factors. Decentralized testing and the ability to get rapid test results is emerging as a tool for more efficient diagnosis and patient evaluation, and to improve the quality of patient care.

This report provides a realistic assessment acknowledging the reality of payors’ emphasis on cost/benefit analysis for new technologies. Current sales and predictions for 2017 sales are provided for the diabetes, oncology, cardiac marker, pregnancy and other LF test markets.

Kalorama’s unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.

For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with device company representatives included marketing directors, division managers, and product development representatives.

The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2012 to 2017.

Related Reports:

The United States Market for In Vitro Diagnostic Tests
Mar 18, 2014 - KLI5217921 - $3,995.00

Retail Clinics Market Overview and 2014 Survey Results
Mar 11, 2014 - KLI5215143 - $750.00

The Market and Potential for Molecular Point of Care Diagnostics
Feb 5, 2014 - KLI5201690 - $3,995.00

IVD in Singapore and Malaysia
Jan 1, 2014 - KLI5177833 - $1,995.00

The World Market for Hematology
Nov 22, 2013 - KLI5156915 - $3,995.00

Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey
Mar 22, 2013 - KLI5007914 - $995.00

The World Market for Point of Care (POC) Diagnostics
Dec 6, 2012 - KLI4891643 - $1,995.00

Retail Clinics 2012: Growth of Stores, Consumer Opinion Surveys, Winning Competitors, Supplier Sales of Products to Clinics, Clinic Sales Forecasts and Trends
Nov 15, 2012 - KLI4911928 - $2,500.00

Cell Phone-Enabled Diagnostics: mHealth Applications in IVD
Aug 15, 2012 - KLI4862659 - $995.00

The Global Market for Medical Devices, 3rd. Edition
May 2, 2012 - KLI3873247 - $1,500.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
Results of The 2012 Kalorama IVD Procedure Count: White Paper
The World Market for Point of Care (POC) Diagnostics
White Paper: Animal Diagnostics: "Sister Market" to IVD?
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
The World Market for Veterinary Diagnostics
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
4/17/2014 - 40
SSL
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST